| GO ID | GO:0030154 |
| Ontology | BP |
| GO Term | cell differentiation |
| Definition | The process in which relatively unspecialized cells, e.g. embryonic or regenerative cells, acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state. |
| Gene Symbol | Description | Entrez ID | Uniprot ID | Chromosomal Location |
|---|---|---|---|---|
ABHD5 | abhydrolase domain containing 5 |
51099 | Q8WTS1 | chr3: 43,690,113-43,734,371 |
ADCYAP1R1 | adenylate cyclase activating polypeptide 1 (pituitary) receptor type I |
117 | P41586 | chr7: 31,052,461-31,111,479 |
ADIRF | adipogenesis regulatory factor |
10974 | Q15847 | chr10: 86,968,192-86,983,934 |
AGR3 | anterior gradient 3, protein disulphide isomerase family member |
155465 | Q8TD06 | chr7: 16,859,405-16,881,987 |
AKT1 | v-akt murine thymoma viral oncogene homolog 1 |
207 | P31749 | chr14: 104,769,349-104,795,751 |
ALKBH5 | alkB homolog 5, RNA demethylase |
54890 | Q6P6C2 | chr17: 18,183,078-18,209,954 |
ANGPT1 | angiopoietin 1 |
284 | Q15389 | chr8: 107,249,482-107,498,055 |
APOLD1 | apolipoprotein L domain containing 1 |
81575 | Q96LR9 | chr12: 12,725,917-12,829,975 |
ARHGAP22 | Rho GTPase activating protein 22 |
58504 | Q7Z5H3 | chr10: 48,446,034-48,656,265 |
ARHGAP24 | Rho GTPase activating protein 24 |
83478 | Q8N264 | chr4: 85,475,114-86,002,670 |
ARHGEF28 | Rho guanine nucleotide exchange factor 28 |
64283 | Q8N1W1 | chr5: 73,626,158-73,941,993 |
ARNT | aryl hydrocarbon receptor nuclear translocator |
405 | P27540 | chr1: 150,809,705-150,876,768 |
ASF1B | anti-silencing function 1B histone chaperone |
55723 | Q9NVP2 | chr19: 14,119,509-14,136,956 |
ATOH8 | atonal bHLH transcription factor 8 |
84913 | Q96SQ7 | chr2: 85,751,344-85,788,066 |
BEX1 | brain expressed X-linked 1 |
55859 | Q9HBH7 | chrX: 103,062,651-103,064,240 |
BZW2 | basic leucine zipper and W2 domains 2 |
28969 | Q9Y6E2 | chr7: 16,646,131-16,706,523 |
CADM1 | cell adhesion molecule 1 |
23705 | Q9BY67 | chr11: 115,169,218-115,504,957 |
CAND1 | cullin-associated and neddylation-dissociated 1 |
55832 | Q86VP6 | chr12: 67,269,281-67,319,951 |
CCDC85B | coiled-coil domain containing 85B |
11007 | Q15834 | chr11: 65,890,112-65,891,635 |
CDC5L | cell division cycle 5 like |
988 | Q99459 | chr6: 44,387,525-44,450,426 |
CENPF | centromere protein F |
1063 | P49454 | chr1: 214,603,195-214,664,588 |
CITED2 | Cbp/p300-interacting transactivator, with Glu/Asp rich carboxy-terminal domain, 2 |
10370 | Q99967 | chr6: 139,371,807-139,374,620 |
CLPTM1 | cleft lip and palate associated transmembrane protein 1 |
1209 | O96005 | chr19: 44,954,585-44,993,341 |
COL13A1 | collagen, type XIII, alpha 1 |
1305 | Q5TAT6 | chr10: 69,801,931-69,964,275 |
COL15A1 | collagen, type XV, alpha 1 |
1306 | P39059 | chr9: 98,943,179-99,070,792 |
CPLX2 | complexin 2 |
10814 | Q6PUV4 | chr5: 175,796,310-175,884,020 |
CREBL2 | cAMP responsive element binding protein-like 2 |
1389 | O60519 | chr12: 12,611,827-12,645,108 |
CREM | cAMP responsive element modulator |
1390 | Q03060 | chr10: 35,126,791-35,212,958 |
CSK | c-src tyrosine kinase |
1445 | P41240 | chr15: 74,782,057-74,803,198 |
CSPG5 | chondroitin sulfate proteoglycan 5 |
10675 | O95196 | chr3: 47,562,239-47,580,792 |
CSRP2 | cysteine and glycine rich protein 2 |
1466 | Q16527 | chr12: 76,858,715-76,879,060 |
CTGF | connective tissue growth factor |
1490 | P29279 | chr6: 131,948,176-131,951,373 |
DAPL1 | death associated protein like 1 |
92196 | A0PJW8 | chr2: 158,795,317-158,862,781 |
DAZAP1 | DAZ associated protein 1 |
26528 | Q96EP5 | chr19: 1,407,569-1,435,687 |
DHCR7 | 7-dehydrocholesterol reductase |
1717 | Q9UBM7 | chr11: 71,428,193-71,452,868 |
DLK1 | delta-like 1 homolog (Drosophila) |
8788 | P80370 | chr14: 100,725,705-100,738,224 |
DUSP6 | dual specificity phosphatase 6 |
1848 | Q16828 | chr12: 89,347,232-89,353,271 |
EDARADD | EDAR-associated death domain |
128178 | Q8WWZ3 | chr1: 236,348,257-236,484,914 |
EID1 | EP300 interacting inhibitor of differentiation 1 |
23741 | Q9Y6B2 | chr15: 48,877,886-48,880,183 |
EID2 | EP300 interacting inhibitor of differentiation 2 |
163126 | Q8N6I1 | chr19: 39,538,705-39,540,333 |
ELAVL3 | ELAV like neuron-specific RNA binding protein 3 |
1995 | Q14576 | chr19: 11,451,326-11,481,046 |
ELF5 | E74-like factor 5 (ets domain transcription factor) |
2001 | Q9UKW6 | chr11: 34,478,793-34,513,805 |
ELK1 | ELK1, member of ETS oncogene family |
2002 | P19419 | chrX: 47,635,521-47,650,604 |
ELK3 | ELK3, ETS-domain protein (SRF accessory protein 2) |
2004 | P41970 | chr12: 96,194,382-96,269,835 |
ERF | Ets2 repressor factor |
2077 | P50548 | chr19: 42,247,572-42,255,157 |
ETS2 | v-ets avian erythroblastosis virus E26 oncogene homolog 2 |
2114 | P15036 | chr21: 38,805,307-38,824,955 |
ETV5 | ets variant 5 |
2119 | P41161 | chr3: 186,046,308-186,110,318 |
EXT2 | exostosin glycosyltransferase 2 |
2132 | Q93063 | chr11: 44,095,549-44,245,429 |
EYA4 | EYA transcriptional coactivator and phosphatase 4 |
2070 | O95677 | chr6: 133,240,598-133,532,120 |
FAM120B | family with sequence similarity 120B |
84498 | Q96EK7 | chr6: 170,290,703-170,407,065 |
FGR | FGR proto-oncogene, Src family tyrosine kinase |
2268 | P09769 | chr1: 27,612,064-27,635,277 |
FHL1 | four and a half LIM domains 1 |
2273 | Q13642 | chrX: 136,146,702-136,211,359 |
FOXK1 | forkhead box K1 |
221937 | P85037 | chr7: 4,682,309-4,771,443 |
FOXL2 | forkhead box L2 |
668 | P58012 | chr3: 138,944,224-138,947,140 |
FOXN2 | forkhead box N2 |
3344 | P32314 | chr2: 48,314,637-48,379,294 |
FOXN3 | forkhead box N3 |
1112 | O00409 | chr14: 89,124,871-89,619,149 |
FXR1 | fragile X mental retardation, autosomal homolog 1 |
8087 | P51114 | chr3: 180,868,141-180,982,753 |
FYN | FYN proto-oncogene, Src family tyrosine kinase |
2534 | P06241 | chr6: 111,660,332-111,873,452 |
GABPA | GA binding protein transcription factor alpha subunit |
2551 | Q06546 | chr21: 25,734,570-25,772,460 |
GADD45B | growth arrest and DNA damage inducible beta |
4616 | O75293 | chr19: 2,476,122-2,478,259 |
GADD45G | growth arrest and DNA damage inducible gamma |
10912 | O95257 | chr9: 89,605,013-89,606,555 |
GAS7 | growth arrest specific 7 |
8522 | O60861 | chr17: 9,910,609-10,198,551 |
GLRX2 | glutaredoxin 2 |
51022 | Q9NS18 | chr1: 193,096,468-193,106,114 |
GMCL1 | germ cell-less, spermatogenesis associated 1 |
64395 | Q96IK5 | chr2: 69,829,642-69,881,396 |
GNA12 | guanine nucleotide binding protein (G protein) alpha 12 |
2768 | Q03113 | chr7: 2,728,112-2,844,324 |
GPM6B | glycoprotein M6B |
2824 | Q13491 | chrX: 13,771,031-13,938,638 |
GPSM1 | G-protein signaling modulator 1 |
26086 | Q86YR5 | chr9: 136,327,476-136,359,605 |
HERC4 | HECT and RLD domain containing E3 ubiquitin protein ligase 4 |
26091 | Q5GLZ8 | chr10: 67,921,899-68,075,348 |
HES4 | hes family bHLH transcription factor 4 |
57801 | Q9HCC6 | chr1: 998,962-1,000,172 |
HES6 | hes family bHLH transcription factor 6 |
55502 | Q96HZ4 | chr2: 238,238,267-238,240,662 |
HHEX | hematopoietically expressed homeobox |
3087 | Q03014 | chr10: 92,689,951-92,695,646 |
HIP1 | huntingtin interacting protein 1 |
3092 | O00291 | chr7: 75,533,300-75,738,962 |
HTATIP2 | HIV-1 Tat interactive protein 2 |
10553 | Q9BUP3 | chr11: 20,363,685-20,383,783 |
HUWE1 | HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase |
10075 | Q7Z6Z7 | chrX: 53,532,096-53,686,729 |
ILDR2 | immunoglobulin-like domain containing receptor 2 |
387597 | Q71H61 | chr1: 166,895,711-166,975,482 |
INHA | inhibin alpha |
3623 | P05111 | chr2: 219,569,162-219,575,713 |
INHBA | inhibin beta A |
3624 | P08476 | chr7: 41,667,168-41,705,834 |
INHBB | inhibin beta B |
3625 | P09529 | chr2: 120,346,143-120,351,808 |
ITGB1BP1 | integrin subunit beta 1 binding protein 1 |
9270 | O14713 | chr2: 9,403,475-9,423,547 |
JAK1 | Janus kinase 1 |
3716 | P23458 | chr1: 64,833,229-64,966,504 |
JAK2 | Janus kinase 2 |
3717 | O60674 | chr9: 4,984,390-5,128,183 |
KAZALD1 | Kazal-type serine peptidase inhibitor domain 1 |
81621 | Q96I82 | chr10: 101,061,841-101,068,131 |
MAK | male germ cell-associated kinase |
4117 | P20794 | chr6: 10,762,723-10,838,555 |
MAL | mal, T-cell differentiation protein |
4118 | P21145 | chr2: 95,025,677-95,053,996 |
MAPK7 | mitogen-activated protein kinase 7 |
5598 | Q13164 | chr17: 19,377,721-19,383,544 |
MDK | midkine (neurite growth-promoting factor 2) |
4192 | P21741 | chr11: 46,380,756-46,383,837 |
MGP | matrix Gla protein |
4256 | P08493 | chr12: 14,881,181-14,885,926 |
MMP19 | matrix metallopeptidase 19 |
4327 | Q99542 | chr12: 55,835,433-55,842,966 |
MORN2 | MORN repeat containing 2 |
729967 | Q502X0 | chr2: 38,875,962-38,929,072 |
MUSK | muscle, skeletal, receptor tyrosine kinase |
4593 | O15146 | chr9: 110,668,771-110,801,620 |
MYBL1 | v-myb avian myeloblastosis viral oncogene homolog-like 1 |
4603 | P10243 | chr8: 66,562,175-66,614,247 |
MYBL2 | v-myb avian myeloblastosis viral oncogene homolog-like 2 |
4605 | P10244 | chr20: 43,667,019-43,716,496 |
MYT1L | myelin transcription factor 1-like |
23040 | Q9UL68 | chr2: 1,789,113-2,331,260 |
NAA15 | N(alpha)-acetyltransferase 15, NatA auxiliary subunit |
80155 | Q9BXJ9 | chr4: 139,301,455-139,420,033 |
NDRG2 | NDRG family member 2 |
57447 | Q9UN36 | chr14: 21,016,763-21,070,872 |
NDRG4 | NDRG family member 4 |
65009 | Q9ULP0 | chr16: 58,462,846-58,513,628 |
NHS | NHS actin remodeling regulator |
4810 | Q6T4R5 | chrX: 17,375,420-17,735,994 |
NOTCH2NL | notch 2 N-terminal like |
388677 | Q7Z3S9 | chr1: 146,146,203-146,229,026 |
NR1D1 | nuclear receptor subfamily 1 group D member 1 |
9572 | P20393 | chr17: 40,092,787-40,100,725 |
OSGIN1 | oxidative stress induced growth inhibitor 1 |
29948 | Q9UJX0 | chr16: 83,948,282-83,966,332 |
OSR1 | odd-skipped related transciption factor 1 |
130497 | Q8TAX0 | chr2: 19,351,485-19,358,653 |
PARP11 | poly(ADP-ribose) polymerase family member 11 |
57097 | Q9NR21 | chr12: 3,791,047-3,873,448 |
PAX4 | paired box 4 |
5078 | O43316 | chr7: 127,610,292-127,618,114 |
PBXIP1 | pre-B-cell leukemia homeobox interacting protein 1 |
57326 | Q96AQ6 | chr1: 154,944,076-154,956,123 |
PDLIM7 | PDZ and LIM domain 7 |
9260 | Q9NR12 | chr5: 177,483,394-177,497,606 |
PEG10 | paternally expressed 10 |
23089 | Q86TG7 | chr7: 94,656,325-94,669,695 |
PGF | placental growth factor |
5228 | P49763 | chr14: 74,941,834-74,955,784 |
PIWIL4 | piwi-like RNA-mediated gene silencing 4 |
143689 | Q7Z3Z4 | chr11: 94,543,840-94,621,421 |
PLAGL1 | PLAG1 like zinc finger 1 |
5325 | Q9UM63 | chr6: 143,940,300-144,064,599 |
PPARD | peroxisome proliferator-activated receptor delta |
5467 | Q03181 | chr6: 35,342,558-35,428,191 |
PRRC2A | proline-rich coiled-coil 2A |
7916 | P48634 | chr6: 31,620,720-31,637,771 |
PRRC2B | proline-rich coiled-coil 2B |
84726 | Q5JSZ5 | chr9: 131,394,093-131,500,197 |
PURA | purine-rich element binding protein A |
5813 | Q00577 | chr5: 140,107,777-140,125,619 |
PURB | purine-rich element binding protein B |
5814 | Q96QR8 | chr7: 44,876,293-44,885,361 |
RAF1 | Raf-1 proto-oncogene, serine/threonine kinase |
5894 | P04049 | chr3: 12,583,601-12,664,226 |
RBM24 | RNA binding motif protein 24 |
221662 | Q9BX46 | chr6: 17,281,346-17,293,875 |
RBM38 | RNA binding motif protein 38 |
55544 | Q9H0Z9 | chr20: 57,391,407-57,409,333 |
RBM4 | RNA binding motif protein 4 |
5936 | Q9BWF3 | chr11: 66,638,617-66,666,682 |
RBM45 | RNA binding motif protein 45 |
129831 | Q8IUH3 | chr2: 178,112,424-178,139,011 |
RHOB | ras homolog family member B |
388 | P62745 | chr2: 20,447,074-20,449,445 |
RNF114 | ring finger protein 114 |
55905 | Q9Y508 | chr20: 49,936,336-49,953,892 |
RPS3A | ribosomal protein S3A |
6189 | P61247 | chr4: 151,099,573-151,104,652 |
RPS7 | ribosomal protein S7 |
6201 | P62081 | chr2: 3,575,205-3,580,919 |
SFRP4 | secreted frizzled-related protein 4 |
6424 | Q6FHJ7 | chr7: 37,905,932-38,025,695 |
SFRP5 | secreted frizzled-related protein 5 |
6425 | Q5T4F7 | chr10: 97,766,751-97,771,952 |
SH2B3 | SH2B adaptor protein 3 |
10019 | Q9UQQ2 | chr12: 111,405,948-111,451,623 |
SH3PXD2B | SH3 and PX domains 2B |
285590 | A1X283 | chr5: 172,325,000-172,454,523 |
SHB | Src homology 2 domain containing adaptor protein B |
6461 | Q15464 | chr9: 37,919,134-38,069,211 |
SIM1 | single-minded family bHLH transcription factor 1 |
6492 | P81133 | chr6: 100,385,015-100,464,929 |
SIM2 | single-minded family bHLH transcription factor 2 |
6493 | Q14190 | chr21: 36,699,133-36,749,917 |
SLC2A14 | solute carrier family 2 (facilitated glucose transporter), member 14 |
144195 | Q8TDB8 | chr12: 7,812,512-7,891,148 |
SLC7A5 | solute carrier family 7 (amino acid transporter light chain, L system), member 5 |
8140 | Q01650 | chr16: 87,830,023-87,869,488 |
SLCO4C1 | solute carrier organic anion transporter family member 4C1 |
353189 | Q6ZQN7 | chr5: 102,233,986-102,296,549 |
SLFN5 | schlafen family member 5 |
162394 | Q08AF3 | chr17: 35,243,036-35,273,655 |
SOX15 | SRY-box 15 |
6665 | O60248 | chr17: 7,588,178-7,590,170 |
SPATA20 | spermatogenesis associated 20 |
64847 | Q8TB22 | chr17: 50,543,058-50,555,852 |
SPATA24 | spermatogenesis associated 24 |
202051 | Q86W54 | chr5: 139,396,563-139,404,088 |
SPATA9 | spermatogenesis associated 9 |
83890 | Q9BWV2 | chr5: 95,652,181-95,698,711 |
SQSTM1 | sequestosome 1 |
8878 | Q13501 | chr5: 179,806,398-179,838,078 |
SRA1 | steroid receptor RNA activator 1 |
10011 | Q9HD15 | chr5: 140,537,340-140,558,252 |
SRD5A1 | steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1) |
6715 | P18405 | chr5: 6,633,343-6,674,386 |
SRD5A2 | steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2) |
6716 | P31213 | chr2: 31,522,480-31,581,067 |
SRPK2 | SRSF protein kinase 2 |
6733 | P78362 | chr7: 105,110,704-105,399,308 |
STX2 | syntaxin 2 |
2054 | P32856 | chr12: 130,789,600-130,839,266 |
STYK1 | serine/threonine/tyrosine kinase 1 |
55359 | Q6J9G0 | chr12: 10,618,939-10,674,318 |
SUV39H2 | suppressor of variegation 3-9 homolog 2 |
79723 | Q9H5I1 | chr10: 14,878,820-14,904,315 |
TCFL5 | transcription factor-like 5 (basic helix-loop-helix) |
10732 | Q9UL49 | chr20: 62,841,115-62,861,763 |
TDGF1 | teratocarcinoma-derived growth factor 1 |
6997 | P13385 | chr3: 46,574,534-46,582,463 |
TDRD9 | tudor domain containing 9 |
122402 | Q8NDG6 | chr14: 103,928,462-104,052,667 |
TEX15 | testis expressed 15 |
56154 | Q9BXT5 | chr8: 30,831,544-30,890,606 |
TGFB1I1 | transforming growth factor beta 1 induced transcript 1 |
7041 | O43294 | chr16: 31,471,585-31,477,960 |
THEG | theg spermatid protein |
51298 | Q9P2T0 | chr19: 361,747-376,670 |
THSD7A | thrombospondin type 1 domain containing 7A |
221981 | Q9UPZ6 | chr7: 11,370,357-11,832,198 |
TMEM176B | transmembrane protein 176B |
28959 | Q3YBM2 | chr7: 150,791,285-150,801,360 |
TNFAIP2 | TNF alpha induced protein 2 |
7127 | Q03169 | chr14: 103,123,442-103,137,439 |
TNK2 | tyrosine kinase, non-receptor, 2 |
10188 | Q07912 | chr3: 195,863,364-195,911,945 |
TP53 | tumor protein p53 |
7157 | P04637 | chr17: 7,661,779-7,687,550 |
TPT1 | tumor protein, translationally-controlled 1 |
7178 | P13693 | chr13: 45,333,471-45,341,370 |
TUBD1 | tubulin delta 1 |
51174 | Q9UJT1 | chr17: 59,859,482-59,892,945 |
TYMP | thymidine phosphorylase |
1890 | P19971 | chr22: 50,525,752-50,530,056 |
UBE2V1 | ubiquitin conjugating enzyme E2 variant 1 |
7335 | Q13404 | chr20: 50,081,124-50,115,959 |
UHRF2 | ubiquitin-like with PHD and ring finger domains 2, E3 ubiquitin protein ligase |
115426 | Q96PU4 | chr9: 6,413,151-6,507,054 |
USP42 | ubiquitin specific peptidase 42 |
84132 | Q9H9J4 | chr7: 6,104,884-6,161,564 |
WIPF3 | WAS/WASL interacting protein family member 3 |
644150 | A6NGB9 | chr7: 29,806,486-29,917,066 |
YY1 | YY1 transcription factor |
7528 | P25490 | chr14: 100,238,298-100,282,792 |
ZAK | Mitogen-activated protein kinase kinase kinase MLT |
51776 | Q9NYL2 | chr2: 173,075,435-173,268,010 |
ZBTB7A | zinc finger and BTB domain containing 7A |
51341 | O95365 | chr19: 4,044,364-4,066,945 |
ZHX1 | zinc fingers and homeoboxes 1 |
11244 | Q9UKY1 | chr8: 123,248,451-123,275,541 |
ZIC1 | Zic family member 1 |
7545 | Q15915 | chr3: 147,393,422-147,510,293 |
ZNF268 | zinc finger protein 268 |
10795 | Q14587 | chr12: 133,181,409-133,214,831 |
ZNF423 | zinc finger protein 423 |
23090 | Q2M1K9 | chr16: 49,487,524-49,857,919 |
ZSCAN2 | zinc finger and SCAN domain containing 2 |
54993 | Q7Z7L9 | chr15: 84,600,986-84,627,796 |